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Abstract
Objective: To evaluate the coverage and timeliness of the Expanded Programme on Immunisation (EPI) in The Gambia.
Methods: Vaccination data were obtained between January 2005 and December 2012 from the Farafenni Health and
Demographic Surveillance System (FHDSS), the Basse Health and Demographic Surveillance System (BHDSS), the Kiang West
Demographic surveillance system (KWDSS), a cluster survey in the more urban Western Health Region (WR) and a cross
sectional study in four clinics in the semi-urban Greater Banjul area of WR. Kaplan-Meier survival function was used to
estimate the proportion vaccinated by age and to assess timeliness to vaccination.
Findings: BCG vaccine uptake was over 95% in all regions. Coverage of DPT1 ranged from 93.2% in BHDSS to 99.8% in the
WR. Coverage decreased with increasing number of DPT doses; DPT3 coverage ranged from 81.7% in BHDSS to 99.0% in
WR. Measles vaccination coverage ranged from 83.3% in BHDSS to 97.0% in WR. DPT4 booster coverage was low and
ranged from 43.9% in the WR to 82.8% in KWDSS. Across all regions, delaying on previous vaccinations increased the
likelihood of being delayed for the subsequent vaccination.
Conclusions: The Gambia health system achieves high vaccine coverage in the first year of life. However, there continues to
be a delay to vaccination which may impact on the introduction of new vaccines. Examples of effectively functioning EPI
programmes such as The Gambia one may well be important models for other low income countries struggling to achieve
high routine vaccination coverage.
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Introduction
As the 2015 target date for the Millennium Development Goals
(MDGs) approaches, there is the need to evaluate health
programmes and assess how effective they are. The Expanded
Programme on Immunisation (EPI) has been one of the most
successful global childhood programmes, reducing mortality and
morbidity from vaccine-preventable diseases and providing
opportunities for other interventions. EPI vaccination visits
(usually at birth, 6, 10 and 14 weeks and 9 months of age) are
crucial contact points between a child and the health system,
where vaccines and other essential health care interventions like
Long-Lasting Insecticidal Nets (LLINs), de-worming, vitamin A,
and growth assessments, are given [1].
Despite the EPI’s impact on child health the burden of vaccine-
preventable diseases, particularly in the most vulnerable infants,
remains high [2]. Access to health care, including vaccination,
remains low in many parts of world [3]. The evaluation and
optimisation of vaccination programmes were identified as
priorities at the Strategic Advisory Group of Experts (SAGE)
meeting in 2005, which noted that one size does not fit all.
Immunisation uptake varies across the world and its impact varies
according to differences in epidemiology, health infrastructure and
resources [4]. Though vaccination coverage is an important
measure of access, timing of vaccination is equally important as
immunisation programmes can be successful only if children are
protected prior to exposure. Timing also has implications for the
introduction of other vaccines; for example, until recently there
was an age restriction on the administration of rotavirus vaccine,
thus limiting its use in many countries [5,6]. Delayed administra-
tion of vaccines is common and if the rotavirus vaccine schedule
was to adhere to the Diphtheria-Pertussis-Tetanus (DPT) vaccine
schedule, more than 30% of children would be past the
recommended age at their first DPT dose [7]. Vaccination
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timeliness varies widely between and within countries, and this is
masked by coverage estimates [8]. There have been few studies on
vaccine uptake and predictors for delayed administration in sub-
Saharan Africa [9–11]. However, each country needs to evaluate
its own vaccine programmes for making evidence-based decisions
on vaccine schedules, assessing the suitability of new vaccines, and
monitoring both the local epidemiology of infection/disease and
the available financial resources. Following a yellow fever
epidemic in 1978 in the Upper River Divisions, the EPI was
initiated in The Gambia in May 1979 [12]. The initial vaccines
were BCG, Diphtheria-Tetanus- whole cell Pertussis (DTwP),
measles, oral polio (OPV) and yellow fever. Hepatitis B (HepB)
vaccine was phased into the EPI between 1986 and 1990.
Haemophilus influenzae type b (Hib) vaccine was introduced in
1997 and in 2009 the pentavalent vaccine (DwPT-HepB-Hib)
replaced the DTwP-HepB quadrivalent and monovalent HepB
and Hib vaccines. Pneumococcal conjugate vaccine (PCV) was
also introduced in 2009. The Gambia, unlike most other sub-
Saharan African countries, also provides a booster dose of DPT at
18 months of age. Here we use data sets across The Gambia to
evaluate the coverage and timeliness of the national EPI
programme.
Methods
Ethics statement
Approval was obtained from Gambia Government/Medical
Research Council Joint Ethics Committee.
Study populations and data collection
The Gambia is a small West African country with a population
of under 2 million, an annual gross national income per capita of
$1,750 and an under five mortality rate of 101 per 1000 live births
(http://www.who.int/countries/gmb/en/). Data sources were
obtained from four different geographical regions; Western health
Region (WR), North Bank Region (NBR), Lower River Region
(LRR) and Upper River Region (URR) (Figure 1). The study
design and definition of variables for each of the study sites are
summarised in Table 1.
Vaccination data were obtained from three rural demographic
surveillance sites in The Gambia; the Farafenni Health and
Demographic Surveillance System (FHDSS) [13,14], the Basse
Health and Demographic Surveillance System (BHDSS) [15–17],
and the Kiang West Demographic surveillance system (KWDSS)
[18] (Figure 1). The methods have been already published
elsewhere [13–18]. Briefly, each household within the surveillance
area is visited every 3–4 months to collect information on births,
deaths, in and out migrations, pregnancies, marriages and the
vaccination status of all under-five children.
In June 2010, vaccine coverage in the Western Health Region
(WR) was assessed in 12–23 month olds using the cluster survey
technique recommended by the World Health Organization
[19,20].
Between January 2010 and December 2011, a cross sectional
study was carried out in four clinics in the semi-urban Greater
Banjul area of WR. All children aged 9 to 60 months attending the
well-baby clinics at the Fajikunda, Sukuta, and Serrekunda health
centres and Jammeh Foundation for Peace Hospital (JFPH), and
who had not been involved in previous vaccine trials were invited
to participate. A questionnaire on vaccination status and socio-
demographic characteristics was administered to the caregivers.
Statistical analysis
Vaccine coverage for the primary series (BCG, three doses of
DPT (DPT1, DPT2 and DPT3) and measles vaccines) and the
booster dose of DPT administered at 18 months were calculated.
A child was considered to have been vaccinated if a vaccination
date was recorded and not vaccinated if no vaccination date was
recorded. The proportion vaccinated was calculated for BCG and
measles vaccines and by the number of DPT vaccine doses as the
number of vaccinated children divided by the total number of
surveyed children eligible for vaccination at time of interview
according to the vaccination schedule (Table 2). A DPT booster
dose is defined as one dose of DPT given at least one year after the
last DPT dose in the primary series. Median age and interquartile
ranges (IQR) for each dose of BCG, measles and DPT were
calculated.
Yearly birth cohorts were used (instead of calendar year) so that
denominators and numerators were of the same group and to take
account of delayed vaccinations that went across calendar years.
For each vaccine, the proportion vaccinated by age was estimated
using 1 minus the Kaplan-Meier survival function [21,22].
Censoring for each child occurred at date of vaccination, or if
not vaccinated, at the date of interview.
To assess timeliness of vaccination we used the current Gambia
EPI schedule (schedule 1) and an adapted WHO recommended
age range (schedule 2) (Table 2) [7]. The Kaplan-Meier method
was used to assess timeliness of each vaccination schedule. An
event was defined as having been vaccinated before the upper limit
of age range for each specific vaccine schedule. Those who were
vaccinated after these limits were considered failures. Cox
regression analysis was used to examine factors associated with
Figure 1. Map of The Gambia.WCR: Western Coastal Region; LRR: Lower River Region; CRR: Central River Region; URR: Upper River Region. Dashed
circles represent the demographic surveillance sites: Farafenni Health and Demographic Surveillance System (FHDSS), Basse Health and Demographic
Surveillance System (BHDSS), and Kiang West Demographic surveillance system (KWDSS).
doi:10.1371/journal.pone.0107280.g001
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delayed vaccination for each vaccine. These factors include year of
birth, gender, ethnicity and number of previous delayed vaccina-
tions. Covariates were retained in the model if associations were
observed at the p,0.05 level and/or if they altered substantially
the associations of other effect variables in multivariable analysis.
Statistical analyses were performed using STATA 12.0 statistical
software (StataCorp LP, USA, http://www.stata.com).
Results
A total of 44,544 children were included in this analysis; 77.5%
from URR, 16.1% from NBR, 1.2% from LRR, 2.1% from WR
and 3.2% from the Greater Banjul health facilities. As the sample
sizes from each geographical region varied substantially results are
presented by study site.
Vaccination coverage
Vaccination coverage and age distribution at time of vaccina-
tion were similar across all geographical regions (Figures 2 and 3).
BCG uptake was high with over 95% coverage in all areas. The
median age of BCG vaccination was just under 2 weeks in the
urban WR, and around 3–4 weeks in the rural areas of NBR,
URR and LRR.
A high coverage of the primary series was achieved in all
geographical regions. Coverage of the first dose of DPT ranged
from 93.2% in NBR to 99.8% in the Greater Banjul health
facilities. Coverage for two doses ranged from 90.1% in URR to
99.8% in the Greater Banjul health facilities. A slightly lower
coverage of three doses of DPT was observed across all regions;
ranging from 81.7% in URR to 99.0% in Greater Banjul clinics.
The median age that DPT doses were received ranged between
2.5 (IQR 2.1–3.0) and 2.8 (IQR 2.3–3.6) months for DPT1,
between 3.9 (IQR3.4–4.7) and 4.4 (IQR3.7–5.7) months for DPT2
and between 5.3 (IQR 4.6–6.4) and 6.2 (IQR 5.0–8.0) months of
age for DPT3, with West Kiang being closest to the prescribed
schedule. Measles vaccination coverage ranged from 83.3% in
URR to 97.0% in Greater Banjul clinics. The median age for
measles vaccination was similar across all regions, ranging from
9.0 (IQR 8.5–9.6) to 9.9 (IQR 9.2–11.0) months. The coverage for
the DPT booster dose was much lower compared to those of the
primary series; ranging from 43.9% in the WR to 82.8% in West
Kiang. The median age ranged between 18.0 (IQR 16.4–19.7)
and 19.2 (IQR 17.4–21.5) months.
Proportion vaccinated by age
The proportion vaccinated by age for each vaccine was
estimated using 1 minus the Kaplan-Meier survival function
(Figure 4). Further details for each specific geographical region are
shown in Tables S1a-e in File S1. By the end of one month of life,
approximately 50–60% of children were estimated to have been
vaccinated with BCG in the rural areas of NBR, URR and LRR.
Over 80% of children in the WR had received BCG vaccination
by the end of their first month.
Using schedule 1, the proportion vaccinated on time with DPT1
ranged from 55.8% (95% CI: 55.31–56.36) in URR to 96.1%
(95% CI: 94.1–97.5) in West Kiang, LRR. The proportion
Table 1. General characteristics of the study population and study sites to evaluate the Expanded Programme on Immunisation in
the Gambia between January 2005 and December 2012.
Study site Population Study design
Total population
surveyed
Date of data
collection period
Age range for data
collection
North bank region 42 rural villages and Farafenni town
+ satellite villages within 5 km radius,
North Bank Region
HDSS 7,182 Jan 2005–Aug 2012 ,5 years
Upper River Region Southern Bank of the Upper River Region HDSS 34,524 Jan 2005–Dec 2012 ,5 years
Lower river region West Kiang regions DSS and KeMRES 512 Jan 2005– Feb 2012 ,5 years
Western health region Capital of Banjul, the Greater Banjul area
and the Western Coastal Region
EPI cluster survey 923 June 2010 12–23 months
Greater Banjul health
facilities
Fajikunda, Serrekunda, JFPH and Sukuta
HealthClinics
Cross-sectional 1,403 Jan 2010–Dec 2011 .9months -5years
HDSS: Health and Demographic surveillance system; DSS: demographic surveillance system; KeMRES: Keneba Electronic Medical Records System; EPI: Expanded
Programme of Immunisation.
doi:10.1371/journal.pone.0107280.t001
Table 2. Age for WHO recommended routine vaccinations in the Gambia.
Schedule 1 Schedule 2
Vaccinations Current EPI routine Gambian Schedule Adapted WHO recommended age range for vaccination [7]
BCG/OPV/HebB Birth Birth-8 weeks
DTwP-Hib-HepB/PCV/OPV 2 months 6 weeks–3 months
DTwP-Hib-HepB/PCV/OPV 3 months 10 weeks–5 months
DTwP-Hib-HepB/PCV/OPV 4 months 14 weeks–7 months
Measles/Yellow Fever/OPV 9 months 38 weeks–12 months
DPT/OPV 18 months 15 months–24 months
doi:10.1371/journal.pone.0107280.t002
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vaccinated on time with DPT2 ranged from 34.4% (95% CI:
33.90–34.92) in URR to 90.1% (95% CI: 87.64–92.75) in West
Kiang, LRR. For DPT3, only 20.3% (95% CI: 19.84–20.70) of
URR children were vaccinated on time compared to 65.8% (95
CI: 61.67–69.92) in West Kiang. For measles vaccine, coverage by
10 months of age ranged from 46.1% (95% CI: 45.51–46.61) in
URR to 73.0% (95% CI: 69.01–76.91) in West Kiang. The
coverage of the DPT booster dose by 19 months of age was less
than 40% in children from URR, NBR and the Western regions.
72.3% (95% CI: 67.94–76.59) of children vaccinated with the
DPT booster dose in West Kiang, did so on time (Figure 4a).
Using schedule 2, the patterns on time vaccination coverage was
similar to schedule 1 but at higher coverage (Figure 4b).
Figure 2. Frequency distribution of number of vaccinations received by age at vaccination (in weeks) for each of the study sites: a)
North Bank region (2005–2012), b) South bank of the Upper River Region (2005–2012), c) West Kiang, Lower River Region (2005–
2012), d) Western Health Region (June 2010), e) Greater Banjul Health facilities (2010–2011). Blue line: Proportion vaccinated with BCG
vaccine. Brown line: Proportion vaccinated with 1 dose of DPT vaccine. Green line: Proportion vaccinated with 2 doses of DPT vaccine. Orange line:
Proportion vaccinated with 3 doses of DPT vaccine. Blue/Green line: Proportion vaccinated with measles vaccine. Red line: Proportion vaccinated with
DPT booster.
doi:10.1371/journal.pone.0107280.g002
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Predictors for delayed vaccinations
Overall, compared to other study sites, a higher proportion of
children in the URR region were delayed for all vaccinations
(Table 3). Children from West Kiang were more likely to return
on time for vaccination. For BCG vaccine, the proportion
experiencing delays ranged from 2.0% in West Kiang to 14.6%
in URR. An increasing proportion of children were delayed with
increasing number of DPT doses for all study sites; ranging from
1.0%–18.8% for DPT1 and increasing to 5.2%–24.8% for DPT3.
For those vaccinated with measles vaccine, the proportion who
delayed ranged from 1.3% in West Kiang to 19.3% in the Western
health region. Very few children in West Kiang were delayed for
DPT4 (0.55%) compared with 11% of children in URR.
Details of predictors for delay to vaccination for each study site
are shown in Tables S2–S6 in File S1. Across all regions, delaying
on previous vaccinations increased the likelihood of being delayed
for the subsequent vaccination. This association was more strongly
observed for the third dose of DPT. Delay to vaccination for all
vaccines decreased over time between 2005 and 2010 for the NBR
and URR demographic surveillance sites. In NBR and URR
regions, Mandinkas were more likely to be vaccinated on time
compared to Fulas for BCG and DPT1-3 but not for measles or
DPT booster vaccines once adjusted for year of birth and number
of previous delayed vaccinations. In the Western Region clinics
and West Kiang there was no evidence for an association between
ethnic group and being vaccinated on time.
Discussion
The Gambia health system achieves high vaccine coverage in
the first year of life. Vaccination is offered for free and there are
mobile services for remote populations. As a result, vaccination
coverage is over 95% for BCG, .93% for one dose of DPT, and
approximately 90% for 2 doses of DPT. Coverage of the third
dose of DPT and measles are lower, particularly in the URR and
NBR rural areas [13], as is coverage of the fourth dose of DPT at
18 months of age. Coverage of later doses is often lower as parents
are less likely to return to clinics as a child grows, possibly through
emphasis on younger siblings [9], and because of a similar health
system emphasis on infants.
Children receive DPT1 usually between 2–3 months, DPT2
between 3 and 4.5 months and DPT3 between 4–6 months of age.
This observation has important implications, not only for the
success of the DPT vaccines but also for the other vaccines
delivered at these times points, i.e. PCV, HepB, OPV and Hib
vaccines. Timeliness also has implications for the introduction of
other vaccines. Until recently, due to safety concerns, there was an
age restriction on the rotavirus vaccine schedule [5,6]. Clark and
Sanderson examined demographic and health surveys (DHS) in 45
countries (Gambia not included) to estimate vaccination coverage
and delays in administration at national level [7]. They observed
that if the rotavirus vaccine schedule was to adhere to the DPT
schedule then more than 30% of children would be past the
recommended age when they were given the first dose of DPT. In
this study, we observe that 13.51–22.6% in rural areas and 7.91–
14.64% in urban areas would be past the recommended age.
Although, this age restriction has now been lifted, reduced delay
Figure 3. Proportion of eligible children vaccinated and median age (in months) by vaccine type and by region in The Gambia. Blue
bars: proportion who received BCG on time. Brown bars: proportion who received DPT1 on time. Green bars: proportion who received DPT2 on time.
Orange bars: proportion who received DPT2 on time. Turquoise bars: proportion who received measles vaccine on time. Red bars: proportion who
received DPT booster on time. Blue line: Median age (in months) for BCG. Brown line: Median age (in months) for DPT1. Green line: Median age (in
months) for DPT2. Orange line: Median age (in months) for DPT3. Turquoise line: Median age (in months) for measles vaccine. Red line: Median age (in
months) for DPT booster. Vertical bars: Interquartilte range in months of age at vaccination.
doi:10.1371/journal.pone.0107280.g003
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Figure 4. Estimated proportion vaccinated on time by age (months) by vaccine for each geographical region in the Gambia for a)
schedule 1 and b) schedule 2. Blue bars: proportion who received BCG on time. Brown bars: proportion who received DPT1 on time. Green bars:
proportion who received DPT2 on time. Orange bars: proportion who received DPT3 on time. Turquoise bars: proportion who received measles
vaccine on time. Red bars: proportion who received DPT booster on time. Vertical bars: 95% confidence intervals.
doi:10.1371/journal.pone.0107280.g004
Coverage and Timing of Children’s Vaccination
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will further improve safety as well as more infants being protected
at an earlier age
We explored the estimated proportion vaccinated by age and
predictors for delayed vaccination. These are important indicators
for ensuring that vaccines are being delivered before a child is at
risk of acquiring infection and also to develop strategies to improve
age-appropriate vaccination coverage [22]. The proportion
vaccinated on time decreased with increasing return visits for
vaccination but increased over time, indicating that programmes
are continuing their efforts to reach all children on time. The
combined pentavalent and PCV vaccines were introduced in
2009. We observed no change in uptake or increased delays as the
health systems adjusted, which is reassuring and consistent with
observations seen in Kenya [10].
Previous delay in vaccinations was associated with further delay
in later vaccination rather than a reversion to the original
schedule. This applied not only to the primary series but also to
measles and DPT booster doses, suggesting that this may reflect
not only a scheduling knock-on effect but also a tendency for
families who delay initially to continue doing so. Early delayers
may be a group needing the specific attention of the health staff.
This study had potential weaknesses: The DSS data sets depend
on interviewers visiting each home and it is possible that not all
households were visited or all records were adequately collected.
For NBR, this data set represented 59.8% all births in this region
between 2005 and 2012. As noted by Payne and colleagues, those
not surveyed were more likely to come from urban areas and have
higher educational and wealth levels [13]. In URR and West
Kiang, a great effort is placed on visiting all households, and these
datasets include all children [15]. Careful consideration was made
when deciding what years of data to include for each data set.
Although the FDHSS was set up in 1981, a customized enhanced
system was designed in 2005 using the MSDE database engine,
which is part of MS Access. This meant that recording of events
were better monitored. Data previous to 2005 were entered
retrospectively and a decision was thus made to only include the
prospectively collected data from 2005 onwards. This prospective
data collection system was also used for the BDHSS since its
inception and from 2005 onwards for the KWDSS. Thus, the data
collection methods are similar across the years and we are
confident that they are of similar quality. The major strength of
the DSS data sets is that they include a prospective, rigorous and
Table 3. Proportion delayed to vaccination and median delay by vaccine type and by geographical region in The Gambia.
Geographical region Vaccine Total vaccinated (n) % vaccinated who delay
Median
delay1 (weeks)
IQR
(weeks)
BCG 6,738 9.26 3.71 (1.14, 12.93)
DPT1 6,538 8.61 4.00 (1.57, 10.71)
North bank DPT2 6,163 8.71 4.86 (1.71, 13.86)
Region DPT3 5,418 10.5 6.71 (2.57, 16.86)
Measles 4,791 4.97 18.43 (4.93, 35.93)
DPT-Booster 1,238 3.63 11.79 (4.93, 23.50)
BCG 32,490 14.6 4.14 (1.43, 14.86)
South bank, DPT1 32,311 18.83 5.00 (1.86, 13.00)
Upper river DPT2 30,614 20.56 6.71 (2.57, 16.71)
Region DPT3 27,554 24.78 10.42 (4.00, 26.71)
Measles 26,387 10.5 12.50 (4.64, 33.93)
DPT-Booster 9,737 11.1 16.79 (6.21, 33.79)
BCG 501 2 0.78 (0.29, 2.71)
DPT1 509 0.98 1.71 (1.14, 2.00)
West Kiang, DPT2 505 0.4 14.86 (0.29, 29.43)
Lower river DPT3 483 5.18 2.57 (1.86, 17.57)
Region Measles 452 1.33 21.43 (8.36, 46.79)
DPT-Booster 361 0.55 48.29 (3.64, 92.93)
Western BCG 832 6.61 4.00 (1.29, 10.29)
Health DPT1 901 13.1 3.57 (1.29, 8.71)
Region, EPI DPT2 888 15.32 6.07 (2.71, 11.93)
Cluster DPT3 840 19.29 5.93 (3.14, 15.14)
Survey Measles 852 5.75 4.64 (2.64, 13.50)
Greater BCG 1,254 7.89 7.71 (3.00, 16.00)
Banjul DPT1 1,400 7.93 4.14 (1.71, 10.00)
Health DPT2 1,400 11.86 4.86 (1.43, 9.00)
Clinics DPT3 1,389 15.55 6.29 (2.86, 12.26)
Measles 1,345 7.06 8.79 (4.21, 25.79)
IQR: Interquartile range in weeks; 1Median delay estimated from the upper limit of schedule 2 for each vaccine.
doi:10.1371/journal.pone.0107280.t003
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frequent data collection process. The fact that timelines and
uptake patterns are remarkably similar across all the varying data
sets and geographical regions further strengthens the quality of
data.
We did not take into account mortality and some children may
have died before being eligible for vaccination. To include these
children may have underestimated vaccine coverage and increased
the estimate of the magnitude of delay. The design of this work
also assumes that those with a vaccine date had been vaccinated
and those with missing vaccination dates were not vaccinated. The
presence of a vaccination card may be associated with a greater
probability of being vaccinated [22] and to exclude those with no
card may have resulted in underestimating vaccine delay. In all
data sets over 97% of children had a health card. We used 1 minus
the Kaplan-Meier function to estimate the proportion vaccinated
by age consistent with previous studies [7,9–11]. This method is an
easy and useful way of visualizing the vaccination uptake over time
(or age) and provides estimates of the proportion vaccinated at a
given age, which may be useful in assessing the performance of
vaccination programmes in reaching their targets [22]. However,
this method will consistently give higher results than conventional
methods due to censoring, which reduces the population at risk at
the time point when censoring occurs. Also, as the number of
persons under observation decreases with time, the rightward part
of the curve becomes unstable [21]. This would not have
significantly affected the primary series but caution should be
taken when interpreting the delay to DPT4 if the time of interview
was close to the vaccination date.
EPI was initiated in the Gambia in the same year as the Primary
Health Care (PHC) strategy. The primary aim of PHC was
‘‘making health care more accessible and affordable to the
majority of Gambians’’ [23]. Maternal and Child health (MCH)
services form part of the PHC strategy and include delivering
vaccines via static (e.g. health centres and clinics), outreach
(regular services in communities more than 8 kms from health
facilities) and mobile (vaccination teams in defined target
populations) health services throughout the country [12]. These
teams also provide a reliable transport system and ensure the cold
chain is maintained. Before 2009, 5 Dalasi (approx US$0.17) was
charged for a child health card with all subsequent care freely
provided [13]. Thereafter, vaccinations and health care have been
free for all under-5 year olds. The Gambia, like many other sub-
Saharan countries, is a resource -poor country with high under 5
mortality rate and a low GNI (Figure 5). However, these efforts
and a continued strong commitment to reach all children by
providing free vaccines and increasing access with mobile units
have resulted in an EPI programme in The Gambia working well
in terms of coverage and has led to near elimination of Hib disease
in The Gambia [24], a dramatic decline in vaccine-type
pneumococcal incidence (G Mackenzie, unpublished data), a
95% vaccine efficacy against chronic hepatitis B infection after 24
years of hepatitis B vaccination [25], and Gambia being declared
polio free in 2004 [12]. The Decade of Vaccines/Global Vaccine
Action Plan have set the target of achieving 90% coverage for the
first three doses of DPT by 2015 [26]. The results here are
promising but rural areas are still just missing this target.
Timeliness could also be improved, particularly for later doses,
and interventions such early counselling for delayers may assist
this. As we look to and beyond the 2015 Millennium Development
Goal deadline, examples of effectively functioning EPI pro-
grammes such as The Gambia one may well be important models
for other low and middle income countries struggling to achieve
high routine vaccination coverage.
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